ZYME

Zymeworks Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$325m16-Nov-268-K filed 16-Nov-26
Remaining authorization$276mEST16-Nov-268-K filed 16-Nov-26
Program expiry31-Dec-2816-Nov-268-K filed 16-Nov-26
Repurchased last quarter$14m30-Sep-2610-Q filed 09-Nov-26
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
16-Nov-26$200m$200mEST31-Dec-28Second 2026 share repurchase program authorized to repurchase up to $200.0 million of outstanding common stock through 20288-K filed 16-Nov-26
Not found in filings$125m$76mn/aInitial 2026 share repurchase program (completed)10-Q filed 09-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. ≈$14m
    Jul ’26
  2. Aug ’26
  3. ≈$0
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-260—$010-Q filed 09-Nov-26
31-Aug-260—$010-Q filed 09-Nov-26
31-Jul-26534,381$26.16$14m10-Q filed 09-Nov-26
Filings through 16-Nov-26· checked 18-Nov-26